5U91 image
Deposition Date 2016-12-15
Release Date 2017-07-26
Last Version Date 2024-11-06
Entry Detail
PDB ID:
5U91
Keywords:
Title:
Crystal structure of Tre/loxLTR complex
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.10 Å
R-Value Free:
0.25
R-Value Work:
0.20
R-Value Observed:
0.21
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Tre recombinase protein
Mutations:Y324F
Chain IDs:A, B, C (auth: E), D (auth: F)
Chain Length:345
Number of Molecules:4
Biological Source:synthetic construct
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (37-MER)
Chain IDs:E (auth: C), G
Chain Length:37
Number of Molecules:2
Biological Source:Human immunodeficiency virus 1
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (37-MER)
Chain IDs:F (auth: D), H
Chain Length:37
Number of Molecules:2
Biological Source:Human immunodeficiency virus 1
Primary Citation
Crystal structure of an engineered, HIV-specific recombinase for removal of integrated proviral DNA.
Nucleic Acids Res. 45 9726 9740 (2017)
PMID: 28934476 DOI: 10.1093/nar/gkx603

Abstact

As part of the HIV infection cycle, viral DNA inserts into the genome of host cells such that the integrated DNA encoding the viral proteins is flanked by long terminal repeat (LTR) regions from the retrovirus. In an effort to develop novel genome editing techniques that safely excise HIV provirus from cells, Tre, an engineered version of Cre recombinase, was designed to target a 34-bp sequence within the HIV-1 LTR (loxLTR). The sequence targeted by Tre lacks the symmetry present in loxP, the natural DNA substrate for Cre. We report here the crystal structure of a catalytically inactive (Y324F) mutant of this engineered Tre recombinase in complex with the loxLTR DNA substrate. We also report that 17 of the 19 amino acid changes relative to Cre contribute to the altered specificity, even though many of these residues do not contact the DNA directly. We hypothesize that some mutations increase the flexibility of the Cre tetramer and that this, along with flexibility in the DNA, enable the engineered enzyme and DNA substrate to adopt complementary conformations.

Legend

Protein

Chemical

Disease

Primary Citation of related structures